Transactivating effect of complete S protein of hepatitis B virus and cloning of genes transactivated by complete S protein using suppression subtractive hybridization technique

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3893-3898

  Bai, Gui Qin ^a,c   Liu, Yan ^b   Cheng, Jun ^b   Zhang, Shu Lin ^a   Yue, Ya Fei ^a   Huang, Yan Ping ^a   Zhang, Li Yang ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Complete S protein; Hepatitis virus B; Transactivated genes

Indexed keywords

ADAPTOR PROTEIN; BETA GALACTOSIDASE; COMPLEMENTARY DNA; COMPLETE S PROTEIN; DNA FRAGMENT; MESSENGER RNA; PLASMID DNA; RESTRICTION ENDONUCLEASE; TRANSACTIVATOR PROTEIN; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BIOINFORMATICS; CELL CYCLE; CELL METABOLISM; CELL STRAIN HEPG2; CELLULAR IMMUNITY; COMPUTER PROGRAM; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA LIBRARY; DNA SEQUENCE; DNA SYNTHESIS; DNA TRANSFECTION; DNA VECTOR; ENZYME ACTIVITY; ESCHERICHIA COLI; GENBANK; GENE AMPLIFICATION; GENE CONSTRUCT; GENE INSERTION; GENE TARGETING; GENETIC CODE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOMA; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANDOMIZATION; REGULATORY MECHANISM; RESTRICTION FRAGMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TRANSACTIVATION; VIRUS PATHOGENESIS;

EID: 22644435750     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3893     Document Type: Article

References (34)

1. Dong J, Cheng J. Study on definition of pre-per-s region in hepatitis B virus genome. Shijie Huaren Xiaohua Zazhi 2003; 8: 1091-1096
2. Yang Q, Dong J, Cheng J, Liu Y, Hong Y, Wang JJ, Zhuang SL. Definition of pre-pre-s promoter sequence from hepatttis B virus genome and identification of its transcription activtty. Jiefangjun Yixue Zazhi 2003; 9: 761-762
3. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-1956
4. Dong J, Cheng J, Wang Q, Wang G, Shi S, Liu Y, Xia X, Li L, Zhang G, Si C. Quasispecies and variations of hepatitis B virus: core promoter region as an example. Zhonghua Shiyan He Linchuang Bingduxue Zazhi 2002; 16: 264-266
5. Dong J, Cheng J, Wang Q, Shi S, Wang G, Si C. Cloning and analysis of the genomic DNA sequence of augmenter of liver regeneration from rat. Chin Med Sci J 2002; 17: 63-67
6. Deng H, Dong J, Cheng J, Huangfu KJ, Shi SS, Hong Y, Ren XM, Li L. Quasispecies groups in the core promoter region of hepatitis B virus. Hepatobiliary Pancreat Dis Int 2002; 1: 392-396
7. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841
8. Dong J, Cheng J, Wang Q, Huangfu J, Shi S, Zhang G, Hong Y, Li L, Si C. The study on heterogeneity of hepatitis B virus DNA. Zhonghua Yixue Zazhi 2002; 82: 81-85
9. Xia X, Cheng J, Yang J, Zhong Y, Wang G, Fang H, Liu Y, Li K, Dong J. Construction and expression of humanized anti-HBsAg c scFv targeting interferon-alpha in Escherichia coli. Zhonghua Ganzangbing Zazhi 2002; 10: 28-30
10. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68
11. Kuang WW, Thompson DA, Hoch RV, Weigel RJ. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acid Res 1998; 26: 1116-1123
12. Liu Y, Cheng J, Shao DZ, Wang L, Zhong YW, Dong J, Li K, Li L. Synergetic transactivating effect of HCV core and HBV X proteins on SV40 early promoter/enhancer. Zhonghua Shiyan He Linchuang Bingduxue Zazhi 2003; 17: 70-72
13. Huangfu J, Dong J, Deng H, Cheng J, Shi S, Hong Y, Ren X, Li L. A preliminary study on the heterogeneity of preS2 region in hepatitis B virus. Zhonghua Neike Zazhi 2002; 41: 233-236
14. Borchani-Chabchoub I, Mokdad-Gargouri R, Gargouri A. Glucose dependent [correction of dependant] negative translational control of the heterologous expression of the pre-S2 HBV antigen in yeast. Gene 2003; 311: 165-170
15. Soussan P, Pol S, Garreau F, Brechot C, Kremsdorf D. Vaccination of chronic hepatitis B virus carriers with pre-S2/S envelope protein is not associated with the emergence of envelope escape mutants. J Gen Virol 2001; 82: 367-371
16. Park JH, Lee MK, Kim HS, Kim KL, Cho EW. Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope. J Viral Hepat 2003; 10: 70-79
17. Borchani-Chabchoub I, Gargouri A, Mokdad-Gargouri R. Genotyping of Tunisian hepatitis B virus isolates based on the sequencing of pre-S2 and S regions. Microbes Infect 2000; 2: 607-612
18. Tai PC, Suk FM, Gerlich WH, Neurath AR, Shih C. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant the hepatitis B virus variants. Virology 2002; 292: 44-58
19. Hildt E, Urban S, Hofschneider PH. Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene 1995; 11: 2055-2066
20. Bruss V, Lu X, Thomssen R, Gerlich WH. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J 1994; 13: 2273-2279
21. Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH. The Pre-S2 activator MHBs (t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 2002; 21: 525-535
22. Kita Y, Masaki T, Funakoshi F, Yoshida S, Tanaka M, Kurokohchi K, Uchida N, Watanabe S, Matsumoto K, Kuriyama S. Expression of G1 phase-related cell cyclemolecules in naturally developing hepatocellular carcinoma of Long-Evans Cinnamon rats. Int J Oncol 2004; 24: 1205-1211
23. Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. J Cancer 2003; 106: 334-341
24. Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M, Kuriyama S. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003; 37: 534-543
25. Kim H, Lee MJ, Kim MR, Chung IP, Kim YM, Lee JY, Jang JJ. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma. Liver 2000; 20: 173-178
26. Freeman TL, Mailliard ME. Posttranscriptional regulation of ATA2 transport during liver regeneration. Biochem Biophys Res Commun 2000; 278: 729-732
27. Bode BP, Fuchs BC, Hurley BP, Conroy JL, Suetterlin JE, Tanabe KK, Rhoads DB, Abcouwer SF, Souba WW. Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1062-1673
28. Freeman TL, Thiele GM, Tuma DJ, Machu TK, Mailliard ME. ATA2-mediated amino acid uptake following partial hepatectomy is regulated by redistribution to the plasma membrane. Arch Biochem Biophys 2002; 400: 215-222
29. Hatanaka T, Huang W, Wang H, Sugawara M, Prasad PD, Leibach FH, Ganapathy V. Primary structure, functional characteristics and tissue expression pattern of human ATA2, a subtype of amino acid transport system A. Biochim Biophys Acta 2000; 1467: 1-6
30. Villa H, Perez-Pertejo Y, Garcia-Estrada C, Reguera RM, Requena JM, Tekwani BL, Balana-Fouce R, Ordonez D. Molecular and functional characterization of adenylate kinase 2 gene from Leishmania donovani. Eur J Biochem 2003; 270: 4339-4347
31. Kohler C, Gahm A, Noma T, Nakazawa A, Orrenius S, Zhivotovsky B. Release of adenylate kinase 2 from the mitochondrial intermembrane space during apoptosis. FEBS Lett 1999; 447: 10-12
32. Xia J, Yang QD, Yang QM, Xu HW, Liu YH, Zhang L, Zhou YH, Wu ZG, Cao GF. Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a chinese population. Cerebrovasc Dis 2004; 17: 197-203
33. Stefas I, Rucheton M, D'Angeac AD, Morel-Baccard C, Seigneurin JM, Zarski JP, Martin M, Cerutti M, Bossy JP, Misse D, Graafland H, Veas F. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H. Hepatology 2001; 33: 207-217
34. Gao P, Guo Y, Qu L, Shi T, Zhang H, Dong C, Yang H. Relation between Beta-2-glycoprotein I and hepatitis B virus surface antigen Zhonghua Ganzangbing Zazhi 2002; 10: 31-33